Who is sponsoring NCT03574272?

NCT03574272 is sponsored by Asan Medical Center.

What drugs are being tested in NCT03574272?

Interventions in NCT03574272: Patient Transfer Monitoring System.

What condition does NCT03574272 study?

NCT03574272 studies Patient Monitoring.

Is NCT03574272 still recruiting?

NCT03574272 is currently completed. Last updated 8 March 2019.

Last reviewed 2019-03-08 · How we verify

NCT03574272

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Patient Transfer Monitoring System in Hospital Using Mobile IoT Technology

Completed NA Last updated 8 March 2019

What this trial tests

NA trial testing Patient Transfer Monitoring System in Patient Monitoring in 143 participants. Completed in 28 December 2018.

Timeline

16 May 2018

Primary endpoint
28 November 2018

28 December 2018

Quick facts

Lead sponsor	Asan Medical Center
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	other
Enrollment	143
Start date	16 May 2018
Primary completion	28 November 2018
Estimated completion	28 December 2018
Sites	5 locations across South Korea

Drugs / interventions tested

Patient Transfer Monitoring System

Conditions studied

Patient Monitoring — all drugs for Patient Monitoring →

Sponsor

Asan Medical Center

Who can join

Adults 20 to 80, any sex, with Patient Monitoring. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This trial is multi-center prospective study to develop Patient Transfer Monitoring system using mobile lot network and the Risk Factor Detection System and apply to real In-Hospital Patients and verify the efficacy.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Asan Medical Center trials

Trials by the same sponsor.

NCT07530393 — Blood Viscosity and Outcomes After Elective Craniotomy · not yet recruiting
NCT07010497 — A Prospective Study to Evaluate the Safety and Efficacy of the Combination Therapy of Irpagratinib, Atezolizumab, and Be · Phase 2 · recruiting
NCT07382505 — Prospective Cohort Study of Minimal Residual Disease(MRD) Testing for Early Recurrence Detection in Endometrial and Cerv · not yet recruiting
NCT07489092 — Feasibility of a Digital Rehabilitation Platform in Patients After ICU Discharge · NA · recruiting
NCT07431762 — Comparison of Anti-Thrombotic Treatments Between Aspirin and Warfarin During Initial Six Months After Bioprpsthetic Hear · Phase 4 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03574272 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Asan Medical Center
Last refreshed: 8 March 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03574272.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing